Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Dr. Daniel TillettCEO, MD & Director | 400,00k | 357,96k | Derivative Exercise and Retained Stock | 0,89 | 20,27M | 2,01% |
| 2026-05-26 | Dr. Daniel TillettCEO, MD & Director | 400,00k | 358,09k | Derivative Exercise and Retained Stock | 0,90 | 19,87M | 2,05% |
| 2026-05-21 | Dr. Daniel TillettCEO, MD & Director | 248,34k | 221,24k | Derivative Exercise and Retained Stock | 0,89 | 19,47M | 1,29% |
| 2026-05-14 | Dr. Daniel TillettCEO, MD & Director | 200,00k | 180,58k | Derivative Exercise and Retained Stock | 0,90 | 19,22M | 1,05% |
| 2026-05-07 | Dr. Daniel TillettCEO, MD & Director | 200,00k | 181,20k | Derivative Exercise and Retained Stock | 0,91 | 19,02M | 1,06% |
| 2026-04-02 | Dr. Daniel TillettCEO, MD & Director | 200,00k | 172,67k | Derivative Exercise and Retained Stock | 0,86 | 18,82M | 1,07% |
| 2026-02-19 | Dr. Daniel TillettCEO, MD & Director | 100,00k | 88,20k | Derivative Exercise and Retained Stock | 0,88 | 18,62M | 0,54% |
| 2026-02-11 | Dr. Daniel TillettCEO, MD & Director | 62,63k | 63,76k | Achat | 1,02 | 18,52M | 0,34% |
| 2026-02-11 | Dr. Daniel TillettCEO, MD & Director | -14,00k | 14,25k | Vente | 1,02 | 18,52M | -0,08% |
| 2026-01-22 | Dr. Daniel TillettCEO, MD & Director | 400,00k | 341,74k | Derivative Exercise and Retained Stock | 0,85 | 18,47M | 2,21% |
| 2025-12-12 | Dr. Daniel TillettCEO, MD & Director | 300,00k | 248,34k | Derivative Exercise and Retained Stock | 0,83 | 18,07M | 1,69% |
| 2025-12-12 | Dr. Daniel TillettCEO, MD & Director | 12,22k | 20,88k | Achat | 1,71 | 18,07M | 0,07% |
| 2025-11-26 | Dr. Daniel TillettCEO, MD & Director | 22,00k | 38,27k | Achat | 1,74 | 17,76M | 0,12% |
| 2025-11-26 | Dr. Peter Michael SmithExecutive Chairman | 9,43k | 16,31k | Achat | 1,73 | 9,43k | - |
| 2025-11-25 | Dr. Daniel TillettCEO, MD & Director | 432,68k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-25 | Dr. Daniel TillettCEO, MD & Director | -2,00M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-11-25 | Dr. Peter Michael SmithExecutive Chairman | 357,16k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
